PL2083007T3 - Sole tiotropium, sposoby ich wytwarzania oraz zawierające je kompozycje farmaceutyczne - Google Patents

Sole tiotropium, sposoby ich wytwarzania oraz zawierające je kompozycje farmaceutyczne

Info

Publication number
PL2083007T3
PL2083007T3 PL09157299T PL09157299T PL2083007T3 PL 2083007 T3 PL2083007 T3 PL 2083007T3 PL 09157299 T PL09157299 T PL 09157299T PL 09157299 T PL09157299 T PL 09157299T PL 2083007 T3 PL2083007 T3 PL 2083007T3
Authority
PL
Poland
Prior art keywords
same
formulations containing
creating
tiotropium salts
medicinal formulations
Prior art date
Application number
PL09157299T
Other languages
English (en)
Inventor
Rolf Banholzer
Peter Sieger
Waldemar Pfrengle
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34530661&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2083007(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of PL2083007T3 publication Critical patent/PL2083007T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL09157299T 2003-11-03 2004-10-29 Sole tiotropium, sposoby ich wytwarzania oraz zawierające je kompozycje farmaceutyczne PL2083007T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03025076 2003-11-03
EP04791030A EP1682543B1 (de) 2003-11-03 2004-10-29 Verfahren zur herstellung neuer tiotropiumsalze
EP09157299.0A EP2083007B1 (de) 2003-11-03 2004-10-29 Tiotropiumsalze, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittelformulierungen

Publications (1)

Publication Number Publication Date
PL2083007T3 true PL2083007T3 (pl) 2013-09-30

Family

ID=34530661

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09157299T PL2083007T3 (pl) 2003-11-03 2004-10-29 Sole tiotropium, sposoby ich wytwarzania oraz zawierające je kompozycje farmaceutyczne

Country Status (28)

Country Link
US (1) US20050096341A1 (pl)
EP (5) EP1682543B1 (pl)
JP (1) JP5165245B2 (pl)
KR (1) KR20060102561A (pl)
CN (3) CN102964344B (pl)
AR (1) AR046318A1 (pl)
AT (1) ATE478071T1 (pl)
AU (1) AU2004285685B2 (pl)
CA (1) CA2544357A1 (pl)
CO (1) CO5690554A2 (pl)
DE (1) DE502004011562D1 (pl)
DK (2) DK2083007T3 (pl)
EA (1) EA012369B1 (pl)
EC (2) ECSP066545A (pl)
ES (2) ES2350981T3 (pl)
IL (1) IL175127A (pl)
MY (1) MY145166A (pl)
NO (1) NO20061441L (pl)
NZ (1) NZ547523A (pl)
PE (1) PE20050485A1 (pl)
PL (1) PL2083007T3 (pl)
RS (1) RS20060293A (pl)
SG (1) SG149876A1 (pl)
TW (1) TW200523263A (pl)
UA (1) UA82414C2 (pl)
UY (1) UY28589A1 (pl)
WO (1) WO2005042528A1 (pl)
ZA (1) ZA200602343B (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2342468T3 (es) * 2003-11-03 2010-07-07 Boehringer Ingelheim International Gmbh Procedimiento para la preparacion de sales de tiotropio.
NZ564697A (en) * 2005-06-15 2010-04-30 Boehringer Ingelheim Int Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof
CA2611907A1 (en) * 2005-06-17 2006-12-21 Boehringer Ingelheim International Gmbh Mrp iv inhibitors for the treatment of respiratory diseases
DE102005035112A1 (de) * 2005-07-27 2007-02-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neues Verfahren zur Herstellung von Tiotropiumsalzen unter Anwendung von in organischen Lösungsmitteln löslichen N-Methylscopiniumsalzen
US20070167480A1 (en) * 2005-12-19 2007-07-19 Sicor Inc. Pure and stable tiotropium bromide
US9108962B2 (en) 2005-12-19 2015-08-18 Sicor, Inc. Forms of tiotropium bromide and processes for preparation thereof
PT1869035E (pt) * 2005-12-19 2013-01-10 Sicor Inc Novas formas de brometo de tiotrópio e processos para sua preparação
JP2008530251A (ja) * 2005-12-19 2008-08-07 シコール インコーポレイティド 純粋且つ安定な臭化チオトロピウム
US20080051582A1 (en) * 2006-07-10 2008-02-28 Sicor Inc. Process for the preparation of tiotropium bromide
EP1925295A1 (de) * 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Stabile Pulverformulierung enthaltend ein Anticholinergikum
WO2008089852A1 (de) * 2007-01-26 2008-07-31 Boehringer Ingelheim Pharma Gmbh & Co.Kg Neues verfahren zur herstellung von tiotropiumsalzen
EP1953156A1 (de) * 2007-01-29 2008-08-06 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung von Scopiniumsalzen
WO2010110760A1 (en) * 2009-03-27 2010-09-30 Mahmut Bilgic Compositions comprising water with deuterium for the prevention or treatment of allergic diseases and a process for the preparation thereof
PL388070A1 (pl) * 2009-05-19 2010-11-22 Adamed Spółka Z Ograniczoną Odpowiedzialnością Nowe sole tiotropium
CZ201241A3 (cs) * 2012-01-20 2013-07-31 Zentiva, K.S. Nové polymorfní formy tiotropium jodidu a zpusob jejich prípravy
EP2819669B1 (de) * 2012-02-28 2021-04-21 Boehringer Ingelheim International GmbH Neue treibgashaltige tiotropium-formulierung

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2597329A (en) * 1947-08-06 1952-05-20 Merck & Co Inc Process for anion exchange of thiamin salts
US3551492A (en) * 1967-10-31 1970-12-29 Ciba Geigy Corp N,n'-diaminoalkoxy-benzyl-diamino-alkanes and the salts thereof
US4570630A (en) 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
CA1272917A (en) 1985-07-30 1990-08-21 Paul Kenneth Rand Devices for administering medicaments to patients
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE4318455A1 (de) 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
JP4023086B2 (ja) * 1999-12-27 2007-12-19 和光純薬工業株式会社 スルホニウム塩化合物
US6908928B2 (en) * 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
UA75375C2 (en) 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling
OA12522A (en) * 2000-10-12 2006-05-30 Boehringer Ingelheim Pharma Novel tiotropium-containing inhalation powder.
EP1468998A1 (de) * 2000-10-12 2004-10-20 Boehringer Ingelheim Pharma GmbH & Co. KG Kristallines Monohydrat von Tiotropiumbromid und Verfahren zu dessen Herstellung.
US20020111363A1 (en) * 2000-10-31 2002-08-15 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US20020193393A1 (en) * 2001-03-07 2002-12-19 Michel Pairet Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors
HRP20030338B1 (en) * 2000-10-31 2011-09-30 Boehringer Ingelheim Pharma Gmbh & Co. Kg. Inhalative solution formulation containing a titropium salt
US20020183292A1 (en) * 2000-10-31 2002-12-05 Michel Pairet Pharmaceutical compositions based on anticholinergics and corticosteroids
US20020137764A1 (en) * 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
DE10056104A1 (de) * 2000-11-13 2002-05-23 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols
US20020193392A1 (en) * 2000-11-13 2002-12-19 Christel Schmelzer Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
DE10061877A1 (de) * 2000-12-12 2002-06-13 Basf Ag Verfahren zur Herstellung wässriger Copolymerisatdispersionen von Copolymerisaten aus Kohlenmonoxid und wenigstens einer olefinisch ungesättigten Verbindung
DE10064816A1 (de) * 2000-12-22 2002-06-27 Boehringer Ingelheim Pharma Verfahren zur Herstellung eines Anticholinergikums
US6506900B1 (en) * 2001-01-31 2003-01-14 Boehringer Ingelheim Pharma Ag Process for preparing a scopine ester intermediate
US20020193394A1 (en) * 2001-03-13 2002-12-19 Bernd Disse Compounds for treating inflammatory diseases
DE10111843A1 (de) * 2001-03-13 2002-09-19 Boehringer Ingelheim Pharma Verbindungen zur Behandlung von inflammatorischen Erkrankungen
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
US6608055B2 (en) * 2001-06-22 2003-08-19 Boehringer Ingelheim Pharma Kg Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
US6919325B2 (en) * 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
DE10200943A1 (de) * 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern
US20030229227A1 (en) * 2002-03-16 2003-12-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg New difurylglycolic acid esters, processes for the preparation thereof as well as the use thereof as pharmaceutical compositions
DE10212264A1 (de) 2002-03-20 2003-10-02 Boehringer Ingelheim Pharma Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
US20030235538A1 (en) * 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
US6908055B2 (en) * 2003-02-27 2005-06-21 Tandberg Data Asa System for extracting magnetic recording tape from a tape cartridge for engagement with a take-up reel
US20050030040A1 (en) * 2003-06-27 2005-02-10 Mitch Budniak Electrical testing device having voice annunciator
ES2342468T3 (es) * 2003-11-03 2010-07-07 Boehringer Ingelheim International Gmbh Procedimiento para la preparacion de sales de tiotropio.
US7968717B2 (en) * 2003-11-03 2011-06-28 Boehringer Ingelhein International Gmbh Crystalline anhydrate with anticholinergic efficacy
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
SE0303270L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Metod för administration av tiotropium
DE102004041253A1 (de) * 2004-08-26 2006-03-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neues Verfahren zur Herstellung von Tiotropiumsalzen
NZ564697A (en) * 2005-06-15 2010-04-30 Boehringer Ingelheim Int Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
EP2083007B1 (de) 2013-04-24
DK2083007T3 (da) 2013-07-29
NZ547523A (en) 2009-07-31
EP2336127A1 (de) 2011-06-22
ECSP066544A (es) 2006-10-17
ES2422730T3 (es) 2013-09-13
AU2004285685B2 (en) 2011-03-24
EA200600854A1 (ru) 2006-10-27
ECSP066545A (es) 2006-10-17
EA012369B1 (ru) 2009-10-30
ES2350981T3 (es) 2011-01-28
IL175127A0 (en) 2006-09-05
CN101648950A (zh) 2010-02-17
PE20050485A1 (es) 2005-10-05
UA82414C2 (uk) 2008-04-10
DK1682543T3 (da) 2010-12-13
JP5165245B2 (ja) 2013-03-21
AR046318A1 (es) 2005-11-30
IL175127A (en) 2011-10-31
ATE478071T1 (de) 2010-09-15
KR20060102561A (ko) 2006-09-27
ZA200602343B (en) 2007-12-27
EP1682543A1 (de) 2006-07-26
CN1875020B (zh) 2010-04-28
NO20061441L (no) 2006-07-12
WO2005042528A1 (de) 2005-05-12
CN101648950B (zh) 2014-05-07
EP2322522A1 (de) 2011-05-18
CO5690554A2 (es) 2006-10-31
DE502004011562D1 (de) 2010-09-30
HK1099753A1 (zh) 2007-08-24
EP2083007A1 (de) 2009-07-29
MY145166A (en) 2011-12-30
SG149876A1 (en) 2009-02-27
RS20060293A (sr) 2008-08-07
JP2007509895A (ja) 2007-04-19
CN1875020A (zh) 2006-12-06
CN102964344B (zh) 2014-12-31
AU2004285685A1 (en) 2005-05-12
UY28589A1 (es) 2005-06-30
EP2319844A1 (de) 2011-05-11
US20050096341A1 (en) 2005-05-05
CA2544357A1 (en) 2005-05-12
TW200523263A (en) 2005-07-16
CN102964344A (zh) 2013-03-13
EP1682543B1 (de) 2010-08-18

Similar Documents

Publication Publication Date Title
HRP20150039T1 (hr) Farmaceutske formulacije koje sadrže metilnaltrekson
EP1648327A4 (en) ORAL DEVICES AND METHODS OF CONTROLLED MEDICAMENT DELIVERY
PL378065A1 (pl) Podstawione związki N-aryloheterocykliczne, sposób ich wytwarzania oraz ich zastosowanie jako środków leczniczych
PL1690550T3 (pl) Środek do leczenia międzybłoniaka
AU2002319653A1 (en) Method for oral drug delivery
IL174496A0 (en) Aerosol formulation for inhalation, containing an anticholinergic agent
PL2083007T3 (pl) Sole tiotropium, sposoby ich wytwarzania oraz zawierające je kompozycje farmaceutyczne
PL377495A1 (pl) Stały lek do stosowania doustnego
SI1720544T1 (sl) Novi azabicikliäśni derivati, postopek za njihovopripravo in farmacevtski sestavki, ki jih vsebujejo
IL182834A0 (en) Sulfonamido-macrocycles and the salts thereof, a pharmaceutical composition comprisng these compounds, the method of preparing and the use thereof
PL375373A1 (pl) Pochodne imidazopirydyny, sposób ich otrzymywaniai kompozycje farmaceutyczne zawierające te związki
IL175023A0 (en) Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
AU2003218824A8 (en) Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them
HUP0500958A2 (en) 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them, therapeutic use thereof and pharmaceutical compositions containing them
NO20053090D0 (no) Pulverformulering for innhalering inneholdende tiotropium.
AU2003258578A1 (en) Filling device for capsules, in particular medicament capsules
EP1515960A4 (en) 2-THIOXOTHIAZOL DERIVATIVE, METHOD FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF
EP1506180A4 (en) THIAZOLIDINE-4-ONE DERIVATIVE, PROCESS FOR PREPARING THEM, AND PHARMACEUTICAL COMPOSITION BASED ON THE DERIVATIVE
AU2003232684A8 (en) Pyrazole-3-one derivative, method for preparing the same, and pharmaceutical composition containing the same
ZA200601360B (en) Pharmaceutical formulation containing an LTB4 antagonist, method for the production thereof, and use thereof
IL174081A0 (en) Formulation for obtaining a pharmaceutical composition, methods of obtaining and use thereof
EP1693067A4 (en) PHARMACEUTICAL COMPOSITION AGAINST HERPES, METHOD FOR THE PREPARATION OF A DOSAGE FORM AND METHOD FOR THE APPLICATION THEREFOR
SI1558612T1 (sl) Derivati imidazopiridina, postopek za njihovo pripravo in farmacevtski sestavki, ki jih vsebujejo
SI1718673T1 (sl) Postopek za ciscenje albumina, ki obsega stopnjo nanofiltracije, raztopina in sestavek za terapevtsko uporabo, ki le-tega vsebuje
AU2004904679A0 (en) Oral killed vaccines and method for providing same